Cell and Gene Therapy Market Size and Segments - 2031
Cell and Gene Therapy Market: Size and Share
-
CAGR (2023 - 2031)25.8% -
Market Size 2023
US$ 4,485.00 Million -
Market Size 2031
US$ 28,050.39 Million

Market Dynamics
- The increasing number of approvals of cell and gene therapies enhances manufacturing capabilities, which fuels the cell and gene therapy market growth
- Integration of artificial intelligence and automation technologies is likely to remain a key trend in the market
- Increasing strategic initiatives by key players are anticipated to create substantial growth opportunities in the cell and gene therapy market during the forecast period
Market Segmentation

- Cell Therapy
- Gene Therapy

- Process Development
- cGMP Manufacturing
- Regulatory Services
- Bioassay Services

- Pre Commercial/R and D Manufacturing
- Commercial Scale Manufacturing

- CDMOs
- CMOs
Cell and Gene Therapy Market Players Density: Understanding Its Impact on Business Dynamics
The Cell and Gene Therapy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Cell and Gene Therapy Market are:
- Thermo Fisher Scientific, Inc.;
- Merck KGaA;
- Charles River Laboratories;
- Cell and Gene Therapy Catapult;
- Lonza;
- WuXi AppTec;
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Cell and Gene Therapy Market top key players overview